Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Times Observer.
Press releases published on April 2, 2025
Firan Technology Group Corporation (“FTG”) Announces First Quarter 2025 Earnings Release and Conference Call Dates
GlobeNewswire
·
April 2, 2025
TORONTO, April 02, 2025 (GLOBE NEWSWIRE) -- Firan Technology Group Corporation (TSX: FTG) (OTCQX: FTGFF) (“FTG”) will release the first quarter 2025 financial results after the market closes on Wednesday, April 9, 2025. The Corporation will host a live …
Voxtur Announces Adoption of Advance Notice By-Law
GlobeNewswire
·
April 2, 2025
TORONTO and TAMPA, Fla. , April 02, 2025 (GLOBE NEWSWIRE) -- Voxtur Analytics Corp. (TSXV: VXTR; OTCQB: VXTRF) ("Voxtur" or the "Company"), a North American technology company creating a more transparent and accessible real estate lending ecosystem, …
Los resultados financieros de 2024 de ZenaTech y la carta del director ejecutivo a los accionistas muestran un aumento en los ingresos y los activos
GlobeNewswire
·
April 2, 2025
VANCOUVER, Columbia Británica, April 02, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), una empresa de tecnología especializada en drones con IA (inteligencia artificial), Dron como un Servicio (DaaS), …
Richardson Electronics Announces Date of Third Quarter Fiscal Year 2025 Conference Call
GlobeNewswire
·
April 2, 2025
LAFOX, Ill., April 02, 2025 (GLOBE NEWSWIRE) -- Richardson Electronics, Ltd. (NASDAQ: RELL) plans to release its financial results for its third quarter ended March 1, 2025 after the close of business on Wednesday, April 9, 2025. The release will be …
NANOBIOTIX Provides Business Update and Reports Full Year 2024 Financial Results
GlobeNewswire
·
April 2, 2025
Global development program for JNJ-1900 (NBTXR3) proceeding as planned, with opportunity to address one of the largest untapped markets in oncology through lead programs in head and neck cancer and lung cancer Disciplined financial strategy toward long- …
NANOBIOTIX fait le point sur ses activités et publie ses résultats financiers de l’exercice 2024
GlobeNewswire
·
April 2, 2025
Le programme de développement global de JNJ-1900 (NBTXR3) progresse comme prévu, avec l’opportunité d’adresser l’un des plus grands marchés inexploités en oncologie grâce aux programmes les plus avancés dans le cancer de la tête et du cou et le cancer du …
eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO
GlobeNewswire
·
April 2, 2025
Expanded leadership team as eXoZymes ramps up commercial growth Damien Perriman brings more than two decades of experience in successfully developing and commercializing novel biotechnologies Focus on developing commercial opportunities, spin-outs, joint- …
ImmuCell Announces Initiation of Investigational Product Use of Re-Tain®
GlobeNewswire
·
April 2, 2025
PORTLAND, Maine, April 02, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the …
CTR Investments & Consulting Inc. Completes Acquisition of Shibue Couture, Inc.
GlobeNewswire
·
April 2, 2025
PALM DESERT, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- CTR Investments …
GigaCloud Technology Inc Increases Share Repurchase Program by $16 Million
GlobeNewswire
·
April 2, 2025
EL MONTE, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B ecommerce technology solutions for large parcel merchandise, today announced that on March 28, …
Verrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of Directors
GlobeNewswire
·
April 2, 2025
WEST CHESTER, Pa., April 02, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced the …
FibroGen to Participate in the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
April 2, 2025
SAN FRANCISCO, April 02, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the Company will be attending the 24th Annual Needham Virtual Healthcare Conference taking place April 7-10, 2025. FibroGen’s management team will be …
Brookfield Infrastructure to Host First Quarter 2025 Results Conference Call
GlobeNewswire
·
April 2, 2025
BROOKFIELD, NEWS, April 02, 2025 (GLOBE NEWSWIRE) -- Brookfield Infrastructure Partners will hold its first quarter 2025 conference call and webcast on Wednesday, April 30, 2025 at 9:00 a.m. (ET). Results will be released that morning before 7:00 a.m. (ET) …
GRI Bio Announces Closing of $5.0 Million Public Offering
GlobeNewswire
·
April 2, 2025
LA JOLLA, CA, April 02, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and …
Cyclacel Pharmaceuticals Reports Fourth Quarter Financial Results and Provides Business Update
GlobeNewswire
·
April 2, 2025
BERKELEY HEIGHTS, N.J., April 02, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines, today announced fourth quarter financial …
eXoZymes Provides Fourth Quarter and Full Year 2024 Update
GlobeNewswire
·
April 2, 2025
Management to Host Conference Call Today at 4:30PM Eastern Monrovia, CA, April 02, 2025 (GLOBE NEWSWIRE) -- Today, eXoZymes Inc. (NASDAQ: EXOZ) (“eXoZymes”) - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into essential …
Terns Pharmaceuticals Reports Inducement Grant to New Employees Under Nasdaq Listing Rule 5635(C)(4)
GlobeNewswire
·
April 2, 2025
FOSTER CITY, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious …
FormFactor Doubles Capacity at Taiwan Service Center to Meet Growing Demand
GlobeNewswire
·
April 2, 2025
LIVERMORE, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- FormFactor, Inc. (NASDAQ: FORM), a leading provider of test and measurement technologies for the semiconductor industry, is pleased to announce the significant expansion of its Taiwan Service Center. …
BioCryst to Present at Upcoming Investor Conference
GlobeNewswire
·
April 2, 2025
RESEARCH TRIANGLE PARK, N.C., April 02, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans to present at the 24th Annual Needham Virtual Healthcare Conference on Wednesday, April 9, 2025, at 9:30 a …
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 2, 2025
SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to …